Growth Metrics

Innoviva (INVA) EBT Margin (2016 - 2025)

Historic EBT Margin for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to 90.74%.

  • Innoviva's EBT Margin rose 830900.0% to 90.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.81%, marking a year-over-year increase of 546200.0%. This contributed to the annual value of 10.42% for FY2024, which is 521000.0% down from last year.
  • As of Q3 2025, Innoviva's EBT Margin stood at 90.74%, which was up 830900.0% from 72.39% recorded in Q2 2025.
  • Innoviva's 5-year EBT Margin high stood at 12141.74% for Q1 2021, and its period low was 7859.27% during Q1 2025.
  • For the 5-year period, Innoviva's EBT Margin averaged around 1526.99%, with its median value being 125.87% (2021).
  • Within the past 5 years, the most significant YoY rise in Innoviva's EBT Margin was 120211500bps (2021), while the steepest drop was -186190700bps (2021).
  • Over the past 5 years, Innoviva's EBT Margin (Quarter) stood at 611.53% in 2021, then crashed by -61bps to 982.68% in 2022, then skyrocketed by 56bps to 430.5% in 2023, then tumbled by -98bps to 853.36% in 2024, then surged by 111bps to 90.74% in 2025.
  • Its last three reported values are 90.74% in Q3 2025, 72.39% for Q2 2025, and 7859.27% during Q1 2025.